| Name | Title | Contact Details |
|---|
Applied Medical Services is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
HealthSpace Integrated Solutions is a Glen Allen, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ProCare Systems Inc is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Carbon Health is a modern, tech-enabled healthcare company transforming the primary care, urgent care, and virtual care experience. With a team of expert physicians, engineers, and designers, Carbon Health pushes the boundaries of medicine to deliver personal, accessible and high quality care. We aim to give patients connection to their medical records, quick access for immediate and ongoing healthcare needs, and a network of healthcare experts. We want patients to feel as though they have an advocate - like a doctor in their family. With a growing network of trusted clinics, and an end-to-end platform that supports ongoing care management and virtual appointments, Carbon Health ensures world-class care is affordable and always in reach.
Fresenius Kabi is a global health care company that specializes in lifesaving medicines and medical technologies for infusion, transfusion and clinical nutrition. Our expansive portfolio of products and global network of science and manufacturing centers provide essential support for the care of critical and chronically ill patients. We are part of Fresenius SE, a health care group with more than 100 years of experience in pharmaceuticals, medical devices and life sciences. Our employees – more than 35,000 worldwide – develop and deliver injectable pharmaceuticals and infusion systems; blood collection, transfusion and cell technologies; and essential nutrients for parenteral nutrition. We have special expertise in medicines for oncology, infection, anesthesia, analgesia and critical care. Our products are used in all sites of care – from hospitals and clinics to blood and plasma centers, and increasingly in patients’ homes. In biosimilars, we are developing products with a focus on oncology and autoimmune diseases.